| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NINTEDANIB ESYLATE | 212609 | 001 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 100MG BASE | No | No | 2026/04/02 | 2026/04/02 | CIPLA | Prescription |
| NINTEDANIB ESYLATE | 212609 | 002 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 150MG BASE | No | No | 2026/04/02 | 2026/04/02 | CIPLA | Prescription |
| NINTEDANIB ESYLATE | 216915 | 001 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 100MG BASE | No | No | 2026/04/02 | 2026/04/02 | SANDOZ | Prescription |
| NINTEDANIB ESYLATE | 216915 | 002 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 150MG BASE | No | No | 2026/04/02 | 2026/04/02 | SANDOZ | Prescription |
| NINTEDANIB ESYLATE | 219227 | 001 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 100MG BASE | No | No | 2026/04/02 | 2026/04/02 | APOTEX | Prescription |
| NINTEDANIB ESYLATE | 219227 | 002 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 150MG BASE | No | No | 2026/04/02 | 2026/04/02 | APOTEX | Prescription |
| NINTEDANIB ESYLATE | 219283 | 001 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 100MG BASE | No | No | 2026/04/02 | 2026/04/02 | DR REDDYS | Prescription |
| NINTEDANIB ESYLATE | 219283 | 002 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 150MG BASE | No | No | 2026/04/02 | 2026/04/02 | DR REDDYS | Prescription |
| NINTEDANIB ESYLATE | 219819 | 001 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 100MG BASE | No | No | 2026/04/02 | 2026/04/02 | DEXCEL | Prescription |
| NINTEDANIB ESYLATE | 219819 | 002 | ANDA | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 150MG BASE | No | No | 2026/04/02 | 2026/04/02 | DEXCEL | Prescription |